In the UK, there were 14,065 new cases of NHL in the 2-year period between 2015 and 2017.[3] In the US, it is estimated that approximately 74,200 new cases of NHL and 19,970 deaths caused by NHL will have occurred in 2019.[4] NHL is estimated to be the seventh most commonly diagnosed cancer, and the ninth leading cause of cancer-related death.[4] It is more common in males than in females.[4] It is also more common in white people than in black or Hispanic people. NHL is less common in Asian populations, in whom the T-cell subtype is more prevalent. The incidence of lymphomas increases with age. They are uncommon before age 50 years. First-degree relatives of patients with NHL are at approximately 1.7-times increased risk of developing NHL.[5]

BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.

To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.

You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.

Use of this content is subject to our disclaimer